Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 6

Results For "mental"

1027 News Found

Akumentis Healthcare appoints Sachhin Misshra as President
People | April 06, 2026

Akumentis Healthcare appoints Sachhin Misshra as President

With more than two decades of experience, he brings deep expertise in sales, marketing, business transformation, and strategic leadership


Healthcare major QCIL signs solar power pacts with AMPIN and Radiance
Sustainability | April 06, 2026

Healthcare major QCIL signs solar power pacts with AMPIN and Radiance

Phase I to supply clean energy to five facilities, with long-term plans to power 19 hospitals through a 30 MW renewable network


Merck launches high-stakes trial of dual-action eye drug aiming to halt leading cause of blindness
Clinical Trials | April 03, 2026

Merck launches high-stakes trial of dual-action eye drug aiming to halt leading cause of blindness

The trial, dubbed MALBEC, marks the first in a broader late-phase development push for MK-8748, with a second NVAMD study expected to begin later this year


Vyome Holdings bolsters financial position to support VT-1953 pivotal study through 2027
Biotech | April 02, 2026

Vyome Holdings bolsters financial position to support VT-1953 pivotal study through 2027

As of December 31, 2025, the company reported total cash, cash equivalents and short-term investments of approximately $4.94 million


Agilent opens new customer experience center in Mumbai
Technology | April 02, 2026

Agilent opens new customer experience center in Mumbai

The center brings together hands on technology demonstrations, application expertise, and commercial operations


Biogen bags FDA nod for high dose SPINRAZA in spinal muscular atrophy
Drug Approval | April 02, 2026

Biogen bags FDA nod for high dose SPINRAZA in spinal muscular atrophy

The new regimen, delivering 50 mg/5 mL and 28 mg/5 mL doses, offers a higher concentration of the drug for both loading and maintenance phases


Sygnature Discovery appoints Susanne Back as Head of In Vivo Pharmacology
People | April 01, 2026

Sygnature Discovery appoints Susanne Back as Head of In Vivo Pharmacology

She brings 20 years of in vivo pharmacology experience across academia and industry, including senior scientific and leadership roles at Orion Pharma and Charles River


Bristol Myers Squibb reports positive phase 4 data on Cobenfy for schizophrenia patients
News | March 31, 2026

Bristol Myers Squibb reports positive phase 4 data on Cobenfy for schizophrenia patients

The open-label trial involved 105 adults with schizophrenia who were on a stable dose of an oral atypical antipsychotic for at least six weeks


Bavarian Nordic seeks EMA nod for Mpox vaccine in children aged 2–11
Drug Approval | March 31, 2026

Bavarian Nordic seeks EMA nod for Mpox vaccine in children aged 2–11

The trial demonstrated that immune responses in children were non-inferior to adults, with a similar safety profile after two standard doses of MVA-BN


Eli Lilly trial shows combo therapy dramatically improves psoriatic arthritis, obesity outcomes
News | March 30, 2026

Eli Lilly trial shows combo therapy dramatically improves psoriatic arthritis, obesity outcomes

The findings were presented as a late-breaking study at the 2026 American Academy of Dermatology